Trial intelligence / Profile preview

HrEPO in Asphyxia Neonatorum

NCT00945789Phase 2Completed

Sponsor
Tanta University
Start
Oct 2007
Primary completion
Dec 2008
Countries
1
01

Overview

A Phase 2 trial of erythropoietin in hypoxic-ischemic encephalopathy (HIE), sponsored by Tanta University. Started Oct 2007; status: completed.

02

Drugs

erythropoietin
03

Conditions

hypoxic-ischemic encephalopathy (HIE)

Beyond the preview

Go deeper on NCT00945789.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00945789.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call